Texas Court Issues Markman Ruling in Candela's Suit Against Palomar

The following is excerpted from an August 7, 2008 Candela press release available at Business Wire:

Candela Corporation (NASDAQ: CLZR), a global leader in the development and commercialization of advanced aesthetic laser and light-based systems, announced today that the United States District Court for the Eastern District of Texas, Lufkin Division issued the Markman ruling on August 6, 2008 in Candela’s patent lawsuit against Palomar Medical Technologies, Inc. (NASDAQ: PMTI).

In a Markman ruling, a district court hearing a patent infringement case interprets and rules on the scope and meaning of disputed patent claim language regarding the patents in suit. A Markman decision is often a significant factor in the progress and outcome of patent infringement litigation.

In the recently issued Markman Order, the Court adopted interpretations that Candela believes are favorable to Candela on all claim terms that were in dispute in the litigation.

On December 19, 2006, Candela filed a patent infringement complaint against Palomar Medical Technologies, Inc. (NASDAQ: PMTI) in the United States District Court for the Eastern District of Texas, Lufkin Division, asserting that Palomar’s Lux 1540™, Lux DeepIR™, Lux IR™, Lux G™, and Lux Y™ handpieces willfully infringe upon one or more of United States patents: 5,810,801, 6,659,999 and 6,120,497.

Read the full press release here.